The University of Texas Health Science Center at Houston, UT Physicians Center of Population Health Management & Quality, 1200 Binz Street, Suite 730, Houston, TX 77004, United States of America.
UTHealth School of Public Health, 1200 Pressler Street, Houston, TX 77030, United States of America.
Gynecol Oncol. 2024 Nov;190:243-249. doi: 10.1016/j.ygyno.2024.08.027. Epub 2024 Sep 7.
To examine the impact of the COVID-19 pandemic on cervical cancer screening rates of Hispanic individuals compared to non-Hispanic White (NHW) individuals in the United States, whether a responsive surge in catch-up screenings occurred as society adapted to pandemic changes, and to investigate the sociodemographic characteristics between the study populations.
Using cross-sectional data from the All of Us Research Program, which incorporates electronic health record data and survey data from a demographically, geographically, and medically diverse participant group, we assessed the annual cervical cancer screening rates during 2019-2021 by race/ethnicity among eligible individuals ages 21-64.
Among 116,052 unique individuals (78,829 NHW and 37,223 Hispanic), Hispanic individuals had lower annual cervical cancer screening rates than NHWI across the three years studied. They experienced a more significant decrease in screening from 2019 to 2020 (39.27 %) compared to NHWIs (21.15 %) and less of a rebound increase in the following year, 2021 (10.33 % vs 13.83 %). Hispanic individuals aged 50-64 experienced the sharpest decline in screening rates (-43.01 % from 2019 to 2020). Hispanic individuals also experienced greater adverse social conditions, including lack of insurance or employment, lower educational attainment, and lower household income.
Hispanic individuals experienced a more significant decrease in cervical cancer screening rates with the onset of the COVID-19 pandemic compared with NHW individuals and did not experience a robust rebound in cervical cancer screening rates in 2021. As a result, the disparity in cervical cancer screening rates between NHW and Hispanic individuals considerably worsened with the COVID-19 pandemic.
在美国,比较 COVID-19 大流行对西班牙裔个体与非西班牙裔白人(NHW)个体的宫颈癌筛查率的影响,了解社会适应大流行变化时是否会出现及时筛查的激增,以及调查研究人群之间的社会人口统计学特征。
利用美国所有研究计划(All of Us Research Program)的横断面数据,该计划整合了来自具有不同人口统计学、地理位置和医学特征的参与者群体的电子健康记录数据和调查数据,我们评估了在 2019 年至 2021 年期间符合条件的 21 至 64 岁个体的种族/族裔中每年的宫颈癌筛查率。
在 116052 名独特个体中(78829 名 NHW 和 37223 名西班牙裔),西班牙裔个体在三年研究期间的年度宫颈癌筛查率低于 NHWI。与 NHWI 相比(21.15%),他们在 2019 年至 2020 年期间的筛查率下降幅度更大(39.27%),而在次年的反弹幅度较小(10.33%比 13.83%)。50-64 岁的西班牙裔个体经历了筛查率的急剧下降(2019 年至 2020 年下降 43.01%)。西班牙裔个体还经历了更多的不利社会条件,包括缺乏保险或就业、教育程度较低以及家庭收入较低。
与 NHW 个体相比,西班牙裔个体在 COVID-19 大流行开始时经历了更大幅度的宫颈癌筛查率下降,并且在 2021 年没有出现及时筛查率的强劲反弹。因此,COVID-19 大流行极大地加剧了 NHW 和西班牙裔个体之间的宫颈癌筛查率差距。